These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23956881)

  • 1. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders.
    Sharma D
    ISRN Pharm; 2013; 2013():674507. PubMed ID: 23956881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation Development and Evaluation of Fast Disintegrating Tablet of Cetirizine Hydrochloride: A Novel Drug Delivery for Pediatrics and Geriatrics.
    Sharma D; Singh M; Kumar D; Singh G
    J Pharm (Cairo); 2014; 2014():808167. PubMed ID: 26556203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate, cetirizine hydrochloride in combined pharmaceutical dosage form: a new era in novel drug delivery for pediatrics and geriatrics.
    Sharma D; Singh G; Kumar D; Singh M
    J Drug Deliv; 2015; 2015():640529. PubMed ID: 25810924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and
    Sharma D; Singh R; Singh G
    Turk J Pharm Sci; 2018 Apr; 15(1):29-37. PubMed ID: 32454637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate.
    Kumar A; Saharan VA
    Turk J Pharm Sci; 2017 Apr; 14(1):40-48. PubMed ID: 32454593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK
    Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, Optimization and
    Ejeta F; Gabriel T; Joseph NM; Belete A
    Curr Drug Deliv; 2022; 19(1):129-141. PubMed ID: 34126894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.
    Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT
    Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hordeum vulgare hull in the design of fast disintegrating tablets.
    Rajpurohit H; Sharma P; Sharma S; Purohit S; Bhandari A
    J Young Pharm; 2011 Jul; 3(3):211-5. PubMed ID: 21897660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation design of fast disintegrating tablets using disintegrant blends.
    Shirsand SB; Suresh S; Swamy PV; Para MS; Nagendra Kumar D
    Indian J Pharm Sci; 2010 Jan; 72(1):130-3. PubMed ID: 20582206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient's Compliance.
    Juan C; Gallo L; Gonzalez Vidal N
    AAPS PharmSciTech; 2024 Apr; 25(4):79. PubMed ID: 38589718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of fast dissolving tablets of cinnarizine using superdisintegrant blends and subliming material.
    Basu B; Bagadiya A; Makwana S; Vipul V; Batt D; Dharamsi A
    J Adv Pharm Technol Res; 2011 Oct; 2(4):266-73. PubMed ID: 22247895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters.
    Dhakal B; Thakur JK; Mahato RK; Rawat I; Rabin DC; Chhetri RR; Shah KP; Adhikari A; Pandey J
    ScientificWorldJournal; 2022; 2022():9618344. PubMed ID: 35645632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of rizatriptan benzoate mouth disintegrating tablets.
    Keny RV; Desouza C; Lourenco CF
    Indian J Pharm Sci; 2010 Jan; 72(1):79-85. PubMed ID: 20582194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization.
    Gupta MM; Gupta N; Chauhan BS; Pandey S
    J Pharm (Cairo); 2014; 2014():568320. PubMed ID: 26556198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
    Sadeghi M; Hemmati S; Hamishehkar H
    Drug Dev Ind Pharm; 2016; 42(5):769-75. PubMed ID: 26289005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
    Sadeghi M; Hemmati S; Hamishehkar H
    Drug Dev Ind Pharm; 2016 May; 42(5):769-775. PubMed ID: 26275030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.